Skip to main content
  • Ticagrelor Alone Reduces Bleeding vs. DAPT without Increasing Ischemic Risk Regardless of BMI: TWILIGHT Post Hoc Analysis

    Ticagrelor monotherapy reduced bleeding events without increasing the risk of ischemic events compared to ticagrelor plus aspirin across different body mass index (BMI) categories, according to new study results.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details